Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Corrigendum to 'Patient-Reported Outcomes With Consolidation Durvalumab Versus Placebo After Concurrent Chemoradiotherapy in Limited-Stage SCLC: Results From the Phase 3 ADRIATIC Trial' [Journal of Thoracic Oncology volume 21 issue 6 (2026) 103564].
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 24, 2026
Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1.
Journal: Cancer discovery
Published: October 07, 2025
Patient-Reported Outcomes with Consolidation Durvalumab Versus Placebo Following Concurrent Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer: Results from the Phase 3 ADRIATIC Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: September 04, 2025
Patient-Reported Outcomes With Consolidation Durvalumab Versus Placebo After Concurrent Chemoradiotherapy in Limited-Stage SCLC: Results From the Phase 3 ADRIATIC Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: September 04, 2025
Adverse events self-reported by patients with extensive-stage small-cell lung cancer in the phase III CASPIAN study.
Journal: Future oncology (London, England)
Published: May 07, 2025
Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary.
Journal: Future oncology (London, England)
Published: March 25, 2025
Intracranial activity of sotorasib vs docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer from a global, phase 3, randomized controlled trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 25, 2025
Innovative Quantitative Analysis for Disease Progression Assessment in Familial Cerebral Cavernous Malformations.
Journal: IEEE transactions on bio-medical engineering
Published: March 03, 2025
Durvalumab Plus Platinum-Etoposide in Extensive-Stage Small-Cell Lung Cancer: Outcomes in Age, Sex, and Platinum Subgroups From the Phase 3 CASPIAN Study.
Journal: Clinical lung cancer
Published: February 19, 2025
Reply to P. de Boissieu et al.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 09, 2024
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer.
Journal: The New England journal of medicine
Published: September 13, 2024
Last Updated: 09/26/2026